Signaling pathways
-
BA3489 3-IN-PP1Summary: 3-IN-PP1 is a protein kinase D (PKD) inhibitor. - BA3490 LDC7559Summary: LDC7559 is an inhibitor of eliminatin D.
- BA3491 PenCBSummary: PenCB (PCB118) induces inflammation through initiation and activation-dependent NLRP3 inflammasome.
- BA3492 GSK2982772Summary: GSK2982772 is an orally available, potent ATP-competitive enzyme inhibitor.
- BA3493 WEHI-345Summary: WEHI-345 is a potent and selective inhibitor.
- BA3494 GSK840Summary: GSK840 (GSK'840) is a receptor-interacting protein kinase 3 inhibitor.
- BA3495 GSK547Summary: GSK547 (GSK'547) is a potent and selective inhibitor.
- BA3496 RIPA-56Summary: RIPA-56 is a highly selective and metabolically stable inhibitor of receptor-interacting protein 1.
- BA3497 GSK963Summary: GSK963 is a chiral, potent and selective inhibitor.
- BA3498 HS-1371Summary: HS-1371 is a highly efficient, ATP-competitive inhibitor.